» Articles » PMID: 2441694

The Structure of Hepatitis B Surface Antigen and Its Antigenic Sites

Overview
Journal Bioessays
Publisher Wiley
Date 1987 Jun 1
PMID 2441694
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Ho J, Jeevan-Raj B, Netter H Viruses. 2020; 12(2).

PMID: 31973017 PMC: 7077199. DOI: 10.3390/v12020126.


Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.

Janitzek C, Matondo S, Thrane S, Nielsen M, Kavishe R, Mwakalinga S Malar J. 2016; 15(1):545.

PMID: 27825348 PMC: 5101663. DOI: 10.1186/s12936-016-1574-1.


Antiviral treatment of chronic hepatitis B virus (HBV) infections.

De Clercq E, Ferir G, Kaptein S, Neyts J Viruses. 2011; 2(6):1279-1305.

PMID: 21994680 PMC: 3185710. DOI: 10.3390/v2061279.


Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine.

Makidon P, Bielinska A, Nigavekar S, Janczak K, Knowlton J, Scott A PLoS One. 2008; 3(8):e2954.

PMID: 18698426 PMC: 2496893. DOI: 10.1371/journal.pone.0002954.


Evaluation of Aspergillus niger as host for virus-like particle production, using the hepatitis B surface antigen as a model.

Pluddemann A, van Zyl W Curr Genet. 2003; 43(6):439-46.

PMID: 12802503 DOI: 10.1007/s00294-003-0409-0.